Avidity Biosciences (RNA) Competitor Comparison
We are evaluating the key criteria listed to compare Avidity Biosciences (RNA) against its competitors in the Biotechnology industry.
Market Capitalization
114 / 368Gross Profits
250 / 278Total Revenue
185 / 300EBITDA
291 / 337Free Cashflow
288 / 352Quick Ratio
66 / 357Earnings per Share
253 / 359Dividend yield
0 / 6Total Cash
56 / 358Performance 3 years
44 / 368Performance 5 years
78 / 368Performance 10 years
65 / 368Linearity 3 years
332 / 368Linearity 5 years
320 / 368Linearity 10 years
318 / 368Total Rank
206 / 368Dividend Rank
21 / 368Valuation Rank
89 / 368Piotroski Rank
246 / 368Muliplier Rank
285 / 368Dividend Rank - RNA ranking 21 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.